| __timestamp | Exelixis, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 855506000 |
| Thursday, January 1, 2015 | 96351000 | 996170000 |
| Friday, January 1, 2016 | 95967000 | 1047690000 |
| Sunday, January 1, 2017 | 112171000 | 1324625000 |
| Monday, January 1, 2018 | 182257000 | 1416476000 |
| Tuesday, January 1, 2019 | 336964000 | 1754540000 |
| Wednesday, January 1, 2020 | 547851000 | 1829537000 |
| Friday, January 1, 2021 | 693716000 | 3051100000 |
| Saturday, January 1, 2022 | 891813000 | 2540300000 |
| Sunday, January 1, 2023 | 1044071000 | 3162900000 |
| Monday, January 1, 2024 | 910408000 | 3630300000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Vertex Pharmaceuticals Incorporated and Exelixis, Inc. have been at the forefront of this race, with their research and development (R&D) spending reflecting their commitment to innovation. Over the past decade, Vertex has consistently outspent Exelixis, with its R&D expenses growing by approximately 270% from 2014 to 2023. In contrast, Exelixis has shown a remarkable increase of over 450% in the same period, indicating a significant ramp-up in their innovation efforts.
By 2023, Vertex's R&D spending reached a peak, nearly tripling its 2014 figures, while Exelixis also hit a new high, more than five times its initial spending. This trend underscores the increasing importance of R&D in driving pharmaceutical advancements and highlights the strategic priorities of these two industry leaders.
AbbVie Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Vertex Pharmaceuticals Incorporated or Exelixis, Inc.: Who Leads in Yearly Revenue?
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Vertex Pharmaceuticals Incorporated vs Veracyte, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Insights: How Exelixis, Inc. and CymaBay Therapeutics, Inc. Allocate Funds
Exelixis, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Research and Development Investment: Exelixis, Inc. vs Alkermes plc
R&D Insights: How Exelixis, Inc. and Amicus Therapeutics, Inc. Allocate Funds